These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 13680537)

  • 41. Contrast-induced nephropathy: pathophysiology and preventive strategies.
    Jorgensen AL
    Crit Care Nurse; 2013 Feb; 33(1):37-46. PubMed ID: 23377156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Etiology of iodinated radiocontrast nephrotoxicity and its attenuation by beraprost].
    Yano T
    Yakugaku Zasshi; 2008 Jul; 128(7):1023-9. PubMed ID: 18591870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adverse reactions to intravenous iodinated contrast media: an update.
    Namasivayam S; Kalra MK; Torres WE; Small WC
    Curr Probl Diagn Radiol; 2006; 35(4):164-9. PubMed ID: 16814003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nephrotoxicity of contrast media--etiopathogenesis and methods of prevention].
    Kolonko A; Wiecek A; Kokot F
    Postepy Hig Med Dosw; 1996; 50(3):245-63. PubMed ID: 8927585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of contrast-induced nephropathy: a pharmacological overview.
    Anderson AL; Smith KM
    Orthopedics; 2006 Oct; 29(10):893-5. PubMed ID: 17061415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention.
    Andreucci M; Solomon R; Tasanarong A
    Biomed Res Int; 2014; 2014():741018. PubMed ID: 24895606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors.
    Andreucci M; Faga T; Pisani A; Sabbatini M; Russo D; Michael A
    ScientificWorldJournal; 2014; 2014():823169. PubMed ID: 25525625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contrast media induced nephropathy: a literature review of the available evidence and recommendations for practice.
    Deek H; Newton P; Sheerin N; Noureddine S; Davidson PM
    Aust Crit Care; 2014 Nov; 27(4):166-71. PubMed ID: 24461960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy.
    Heyman SN; Rosen S; Rosenberger C
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):288-96. PubMed ID: 18057308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast-induced nephropathy: nursing implications.
    Isaac S
    Crit Care Nurse; 2012 Jun; 32(3):41-8. PubMed ID: 22661157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention and Management of Adverse Reactions Induced by Iodinated Contrast Media.
    Wu YW; Leow KS; Zhu Y; Tan CH
    Ann Acad Med Singap; 2016 Apr; 45(4):157-64. PubMed ID: 27292007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iodinated contrast medium: Is there a re(n)al problem? A clinical vignette-based review.
    Lakhal K; Ehrmann S; Robert-Edan V
    Crit Care; 2020 Nov; 24(1):641. PubMed ID: 33168006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrast induced nephropathy: an update on diagnosis, predictors, implications and preventive strategies.
    Sholy H; Zukermann R; Soni A; Nikolsky E
    Minerva Med; 2012 Dec; 103(6):465-86. PubMed ID: 23229367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Contrast nephropathy and its prevention].
    Skulec R; Bĕlohlávek J; Kovárník T; Linhart A; Aschermann M
    Vnitr Lek; 2003 Feb; 49(2):127-33. PubMed ID: 12728580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy.
    Prasad PV; Priatna A; Spokes K; Epstein FH
    J Magn Reson Imaging; 2001 May; 13(5):744-7. PubMed ID: 11329196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view.
    Idé JM; Lancelot E; Pines E; Corot C
    Invest Radiol; 2004 Mar; 39(3):155-70. PubMed ID: 15076008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety essentials: acute reactions to iodinated contrast media.
    Iyer RS; Schopp JG; Swanson JO; Thapa MM; Phillips GS
    Can Assoc Radiol J; 2013 Aug; 64(3):193-9. PubMed ID: 22560565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Iodinated contrast media and the kidney.
    Weisbord SD
    Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetylcysteine and contrast media nephropathy.
    Tepel M; Zidek W
    Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):503-6. PubMed ID: 12187314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contrast-induced nephropathy: prevention and management of high-risk patients.
    Caixeta A; Nikolsky E; Mehran R
    Indian Heart J; 2008; 60(6):524-31. PubMed ID: 19276490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.